ACE2 and COVID-19: Despite its distribution throughout the human tissues, it has been shown that ACE2-expressing organs do not behave in a regular pattern which is one of the matter of deep concern for different clinical COVID-19 disease outcomes [19], suggesting more research is needed to widen therapeutic window.